For Year 2025-26, Kobo Biotech reports the following shareholding: Total Promoters at 44.95%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0.66%, and Retail at 54.39%. This breakdown provides a quick snapshot of ownership distribution for Kobo Biotech in 2025-26.